PCT/2001/1 - World Intellectual Property Organization
PCT/2001/1 - World Intellectual Property Organization
PCT/2001/1 - World Intellectual Property Organization
- TAGS
- intellectual
- www.wipo.int
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
01/<strong>2001</strong><br />
4 Jan/jan <strong>2001</strong> <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 37<br />
(72, 75) DALLE CARBONARE, Maurizio<br />
[IT/IT]; Via Compagno, 1, I-35124 Padova<br />
(IT). CALLEGARO, Lanfranco [IT/IT];<br />
Via Monte Grappa, 6, I-36016 Thiene Vicenza<br />
(IT).<br />
(74) VOSSIUS & PARTNER; Siebertstrasse 4,<br />
D-81675 München (DE).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/00191 (13) A2<br />
(21) <strong>PCT</strong>/EP00/06260<br />
(22) 22 Jun/juin 2000 (22.06.2000)<br />
(25) en (26) en<br />
(30) 60/140,642 23 Jun/juin 1999 US<br />
(23.06.1999)<br />
(43) 4 Jan/jan <strong>2001</strong> (04.01.<strong>2001</strong>)<br />
(54) USE OF FOSPHENYTOIN FOR THE<br />
TREATMENT OF ACUTE NEURO-<br />
PATHIC PAIN<br />
UTILISATION DE FOSPHENYTOINE<br />
POUR LE TRAITEMENT DE DOU-<br />
LEUR NEUROPATHIQUE AIGUE<br />
(71) WARNER-LAMBERT COMPANY<br />
[US/US]; 201 Tabor Road, Morris Plains,<br />
NJ 07950 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) MCCLEANE, Gary, John [GB/GB];<br />
58, Kensington Manor, Dollingstown,<br />
Craigavon, Armagh BT66 7HR (GB).<br />
(74) DURNING, Bernard; Warner-Lambert<br />
Company, Parke-Davis, 3-9, Rue de la Loge,<br />
B. P. 100, F-94265 Fresnes Cedex (FR).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ TM<br />
TR TT TZ UA UG US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/00192 (13) A2<br />
(21) <strong>PCT</strong>/FI00/00566<br />
(22) 22 Jun/juin 2000 (22.06.2000)<br />
(25) en (26) en<br />
(30) 60/140,795 25 Jun/juin 1999<br />
(25.06.1999)<br />
(43) 4 Jan/jan <strong>2001</strong> (04.01.<strong>2001</strong>)<br />
US<br />
(54) METHOD OF ADMISTERING AN IM-<br />
IDAZOLE DERIVATIVE TO OBTAIN<br />
ANALGESIA<br />
PROCEDE D’ADMINISTRATION D’UN<br />
DERIVE D’IMIDAZOLE POUR OBTE-<br />
NIR UNE ANALGESIE<br />
(71) ORION CORPORATION [FI/FI]; Orionintie<br />
1, FIN-02200 Espoo (FI).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) HAAPALINNA, Antti [FI/FI];<br />
Markulantie 8 A, FIN-20360 Turku (FI).<br />
LEHTIMÄKI, Jyrki [FI/FI]; Tarhalantie<br />
27, FIN-21570 Sauvo (FI). LEINO, Tiina<br />
[FI/FI]; Heernummentie 20, FIN-21500<br />
Piikkiö (FI). VIITAMAA, Timo [FI/FI];<br />
Kähärintie 2, FIN-20300 Turku (FI). VIR-<br />
TANEN, Raimo [FI/FI]; Knaapintie 2-4 as.<br />
5, FIN-21290 Rusko (FI).<br />
(74) ORION CORPORATION, ORION<br />
PHARMA; Industrial <strong>Property</strong> Rights,<br />
P.O. Box 65, FIN-02101 Espoo (FI).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/00193 (13) A2<br />
(21) <strong>PCT</strong>/IB00/01005<br />
(22) 23 Jun/juin 2000 (23.06.2000)<br />
(25) en (26) en<br />
(30) 60/140,632 23 Jun/juin 1999 US<br />
(23.06.1999)<br />
(43) 4 Jan/jan <strong>2001</strong> (04.01.<strong>2001</strong>)<br />
(54) ZINC IONOPHORES AS ANTI-APOP-<br />
TOTIC AGENTS<br />
IONOPHORES DE ZINC UTILISES<br />
COMME AGENTS ANTI-APOPTOSE<br />
(71) ZINC THERAPEUTICS CANADA, INC.<br />
[CA/CA]; 9th Floor, South Wing, 1 Place<br />
Ville Marie, Montreal, Quebec H3C 3A9<br />
(CA).<br />
(72) FLISS, Henry; 2177 Valley Drive, Ottawa,<br />
Ontario K1G 2P6 (US).<br />
(74) McFADDEN, FINCHAM; Suite 606, 225<br />
Metcalfe Street, Ottawa, Ontario, K2P 1P9<br />
(CA).<br />
(81) AU CA JP.<br />
(84) EP (AT BE CH CY DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/00194 (13) A2<br />
(21) <strong>PCT</strong>/IB00/00791<br />
(22) 13 Jun/juin 2000 (13.06.2000)<br />
(25) en (26) en<br />
(30) 60/141,437 29 Jun/juin 1999<br />
(29.06.1999)<br />
US<br />
(30) 60/177,387 24 Jan/jan 2000 US<br />
(24.01.2000)<br />
(43) 4 Jan/jan <strong>2001</strong> (04.01.<strong>2001</strong>)<br />
(54) A METHOD FOR OPTIMIZING IM-<br />
MUNE ACTIVITY IN THE TREAT-<br />
MENT OF AUTO-IMMUNE DISEASES<br />
AND CHRONIC IMMUNE CONDI-<br />
TIONS<br />
TECHNIQUE PERMETTANT D’OP-<br />
TIMISER UNE ACTIVITE IMMUNE<br />
DANS LE TRAITEMENT DE MALA-<br />
DIES AUTO-IMMUNES ET DE MALA-<br />
DIES IMMUNES CHRONIQUES<br />
(71, 72) JACOBS, Robert, H. [US/US]; East<br />
Tower, Apartment 834, 4335 Marina City<br />
Drive, Marina Del Rey, CA 90292 (US).<br />
(74) CLARK, Ronald, J.; P.O. Box 8539, Newport<br />
Beach, CA 92658 (US).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CU CZ DE DK EE ES FI GB GD<br />
GE GH GM HR HU ID IL IN IS JP KE KG<br />
KP KR KZ LC LK LR LS LT LU LV MD MG<br />
MK MN MW MX NO NZ PL PT RO RU SD<br />
SE SG SI SK SL TJ TM TR TT UA UG US<br />
UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/00195 (13) A2<br />
(21) <strong>PCT</strong>/IL00/00369<br />
(22) 23 Jun/juin 2000 (23.06.2000)<br />
(25) en (26) en<br />
(30) 130638 24 Jun/juin 1999 IL<br />
(24.06.1999)<br />
(43) 4 Jan/jan <strong>2001</strong> (04.01.<strong>2001</strong>)<br />
(54) PHARMACEUTICAL COMPOSITIONS<br />
COMPRISING NITRIC OXIDE SYN-<br />
THASE INHIBITORS<br />
COMPOSITIONS PHARMACEU-<br />
TIQUES CONTENANT DES INHIBI-<br />
TEURS D’OXYDE NITRIQUE SYN-<br />
THASE<br />
(71, 72) COTTER, Gad [IL/IL]; Tzunz Street 15,<br />
68191 Tel Aviv (IL).<br />
(74) REINHOLD COHN AND PARTNERS;<br />
P.O. Box 4060, 61040 Tel-Aviv (IL).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(51) 7 A61K 31/00<br />
(11) WO 01/00196 (13) A2<br />
(21) <strong>PCT</strong>/US00/17432<br />
(22) 26 Jun/juin 2000 (26.06.2000)